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Heterozygous mutations in REEP1 (MIM #609139) encoding the receptor expression-
enhancing protein 1 (REEP1) are a well-recognized and relatively frequent cause of autosomal
dominant hereditary spastic paraplegia (HSP), SPG31.1 REEP1 localizes in the mitochondria
and endoplasmic reticulum (ER) and facilitates ER-mitochondria interactions.2 In addition to
the HSP phenotype, REEP1 has been associated with an autosomal dominant spinal type of
Charcot-Marie-Tooth disease in 2 families.3 More recently, a patient with homozygous REEP1
mutation with a much more severe phenotype akin to spinal muscular atrophy with respiratory
distress type 1 (SMARD1) was reported.4 In this report, we present a patient with a homozygous
mutation in REEP1 manifesting a severe congenital distal spinal muscular atrophy (SMA) with
diaphragmatic paralysis, expanding the phenotype frommild autosomal dominant HSP through
to severe recessive distal SMA pattern.
Clinical report
The proband is a 14-year-old girl who is the product of a normal full-term pregnancy. Her parents
are healthy first-cousin Iranians in their mid-thirties. At birth, she presented with proximal and
distal muscle weakness in all the limbs with flexion contractures at the knees and elbows, foot
drop, and progressive wrist drop (figure1, B–F, Video 1). She could crawl, hold her head erect at
normal age, and sit at the age of 5 months. Afterward, there has been a marked regression in
neurologic development, resulting in permanent inability to stand up and/or walk and in severe
recurrent contractions in hands and feet despite surgery being started from the age of 2.5 years.
She developed progressive muscular atrophy starting from the lower limbs and progressing to the
upper limbs. At the age of 3 years, she was diagnosed with diaphragmatic palsy, resulting in fever-
associated breathing difficulties. She was also diagnosed with esophageal sphincter palsy, which
was corrected by surgery. Her cognition and speech are preserved, and she does not have visual or
hearing impairment.
On neurologic examination, she hadmarked plantar flexion contractures in the ankles and flexion
contractions in the wrists, brisk deep tendon reflexes in the knees, absent Achilles reflex, no
Babinski sign, and normal reflexes in the upper limbs. There was low muscle tone and wasting in
the limbs. Neurophysiology studies showed signs of severe sensory and moderate motor axonal
degeneration, fibrillations, and marked reduction in the motor unit interference pattern with an
increase in amplitude and duration of motor unit action potentials in the right and left tibialis
anterior muscles. The latter change was also observed to a lesser degree in the right biceps and left
deltoid. Sural nerve biopsy was compatible with chronic demyelinating neuropathy with sec-
ondary focal axonal and nerve fibers loss. Brain MRI was unremarkable. Dosage and Sanger
sequencing of the SMN1 gene was performed and resulted negative. The clinical diagnosis of
distal SMA with diaphragmatic paralysis was made. Single-nucleotide polymorphism array
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genotyping in combination with exome sequencing revealed
a homozygous pathogenic missense variant in REEP1 (NM_
022912: c.124T > C; p.Trp42Arg) within a 59 Mb homozy-
gosity region (figure1A).
Discussion
The p.Trp42Arg REEP1 variant has been previously reported
as pathogenic in autosomal dominant hereditary spastic
paraplegia.5 The mutation leads to haploinsufficiency and
interferes with the integrity of the N-terminus of REEP1 and
impairs normal ER targeting and shaping.6 It has been specu-
lated in a Drosophila model that REEP1-associated disorders
could be ER stress diseases expressing variable phenotypes
depending on the type of impaired function in the ER.4 Fur-
thermore, REEP1 could have a direct role in the control of
mitochondrial network morphology through interaction with
the crucial protein involved in mitochondrial fission, named
DRP1. It has been shown that important alterations take place
in the mitochondrial morphology in the primary fibroblasts of
patients with REEP1 HSP compared with control cells.7
To date, only 1 homozygous mutation has been reported in
REEP1; this affects a splice donor site (p.Phe62Lysfs23*) and
was found in a Lebanese patient presenting with a SMARD1-
like phenotype which included distal arthrogryposis, congenital
axonal neuropathy, hyperreflexia, and respiratory distress, but
without any cognitive or language impairment.4 Although there
was a significant phenotypic overlap between this reported
individual and our patient, arthrogryposis involving proximal
and distal joints was more pronounced in our patient, whereas
diaphragmatic palsy seems to be more severe in the homozy-
gous p.Phe62Lysfs23* carrier. In addition, our case adds data on
peculiar electromyographic changes that were not reported in
the former report. Of interest, parents were carriers of the var-
iant in the heterozygous state, already associated with complex
autosomal dominant hereditary spastic paraplegia, and neither
gait problems nor family history of HSP was reported by them.
REEP1 heterozygous mutations express incomplete penetrance
predominantly manifesting before the age of 20 years or after
the age of 30 years.8 Unfortunately, the parents did not have
neurologic and electrophysiologic examinations to exclude the
subclinical or mild forms of HSP. The incomplete penetrance of
the p.Trp42Arg variant in the heterozygous state could be
explained by the effects of modifying genes and stochastic
processes during development.4
The identification of 2 different biallelic REEP1 mutations in
patients with SMARD1-like phenotypes and respiratory Dis-
tress expand the phenotypic spectrum associated to this gene
and demonstrates the loss-of-function dosage effect and impli-
cations of the same allele in distinct neurologic phenotypes.
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Figure Clinical images and molecular genetic findings of
the case
(A) DNA chromatograms. The top row is a sequence from the father, the
middle row is from the mother, and the bottom row is from the proband.
The blue arrow points at A > G substitution, which is heterozygous in the
parents and homozygous in the proband. (B–E) Distal and proximal
arthrogryposis. Wasted limbmuscles. (F) X-ray of the arms. Deformity of the
middle phalanges and lateroflexion of the hand. (G) Family tree.
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